Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement
- PMID: 52404
Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement
Abstract
Two chemically induced, antigenically distinct guinea pig hepatoma cell lines, line 1 and line 10, which are resistant to killing by rabbit anti-Forssman or specific antitumor antibody and complement, can be rendered susceptible when the cells are pretreated with metabolic inhibitors and drugs commonly used for the treatment of cancer patients. The effect appears within 7 hr after initial contact with the inhibitors and is dependent on temperature and on inhibitor concentration; the effect is reversible within 7 hr, and the process of reversion is also temperature dependent. Not all preparations of tumor cells were rendered susceptible following treatment with inhibitors. In some cases, susceptibility to killing by complement was observed with anti-Forssman antibody but not antitumor antibody. No clear correlation between known metabolic inhibitory activity of the inhibitors and conversion to the sensitive state could be made. The results suggest that properties of nucleated cells, which are under metabolic control, play an important role in the killing efficiency of antibody and complement.
Similar articles
-
Inhibition of antibody-complement-mediated killing of tumor cells by hormones.Cancer Res. 1976 Oct;36(10):3672-7. Cancer Res. 1976. PMID: 182362
-
Effect of metabolic inhibitors on the ability of tumor cells to express antigen and bind complement components C4 and C3.Cancer Res. 1975 Nov;35(11 Pt 1):3204-8. Cancer Res. 1975. PMID: 52405
-
Chemotherapeutic drugs increase killing of tumor cells by antibody and complement.Science. 1975 Apr 4;188(4183):55-7. doi: 10.1126/science.46622. Science. 1975. PMID: 46622
-
Selective suppression of humoral immunity by antineoplastic drugs.Annu Rev Pharmacol Toxicol. 1976;16:367-79. doi: 10.1146/annurev.pa.16.040176.002055. Annu Rev Pharmacol Toxicol. 1976. PMID: 779618 Review. No abstract available.
-
Immunologic aspects of cancer chemotherapy.Annu Rev Pharmacol Toxicol. 1977;17:179-95. doi: 10.1146/annurev.pa.17.040177.001143. Annu Rev Pharmacol Toxicol. 1977. PMID: 326163 Review. No abstract available.
Cited by
-
Antibodies as specific carriers for chemotherapeutic agents.Cancer Chemother Pharmacol. 1979;3(1):17-24. doi: 10.1007/BF00254415. Cancer Chemother Pharmacol. 1979. PMID: 394875 Review. No abstract available.
-
Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation.Proc Natl Acad Sci U S A. 1986 Dec;83(23):9144-8. doi: 10.1073/pnas.83.23.9144. Proc Natl Acad Sci U S A. 1986. PMID: 3466179 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources